- TheStreet.com•2 days ago
Spark believes temporary treatment with steroids can arrest the immune response before it causes factor IX levels to fall to a point where bleeding risk becomes a problem.
- Business Wire•2 days agoNew Phase 2 Results Show Investigational Compound Glasdegib Improved Overall Survival in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Today, Pfizer Inc. announced new data from a randomized Phase 2 study of glasdegib , an oral, smoothened inhibitor, showing the addition of glasdegib to low-dose cytarabine significantly increased overall survival when compared to LDAC alone in patients with acute myeloid leukemia or high-risk myelodysplastic syndrome who were ineligible for intensive chemotherapy .
PFE : Summary for Pfizer, Inc. Common Stock - Yahoo Finance
Pfizer Inc. (PFE)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Bid||31.40 x 1500|
|Ask||31.90 x 200|
|Day's Range||31.36 - 31.73|
|52 Week Range||28.25 - 37.39|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||31.76|
|Dividend & Yield||1.20 (3.79%)|
|1y Target Est||N/A|